OWLT Form 4: Director exchanges warrants for 107,626 common shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Owlet, Inc. (OWLT): Director Form 4 filing — On 10/10/2025, a director acquired 107,626 shares of Class A common stock. Following the transaction, the director beneficially owns 233,030 shares, held directly.
The shares were issued in exchange for previously held warrants tied to the company’s Series A (February 2023) and Series B (February 2024) preferred financings, at approximate exchange ratios of 0.61 and 0.56 shares per warrant. Two warrant positions for 131,195 and 48,621 underlying shares were disposed, leaving zero derivative securities.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Kim John C.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Disposition | Warrant (Right to Buy) | 131,195 | $0.00 | -- |
| Disposition | Warrant (Right to Buy) | 48,621 | $0.00 | -- |
| Grant/Award | Common Stock | 107,626 | $0.00 | -- |
Holdings After Transaction:
Warrant (Right to Buy) — 0 shares (Direct);
Common Stock — 233,030 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Owlet (OWLT) disclose in this Form 4 filing?
A director acquired 107,626 shares of common stock on 10/10/2025 and now beneficially owns 233,030 shares directly.
What were the warrant exchange ratios disclosed by Owlet?
Approximately 0.61 shares per warrant for the Series A warrants and 0.56 shares per warrant for the Series B warrants.
Which OWLT derivative positions were disposed?
Warrants covering 131,195 and 48,621 underlying shares were disposed, leaving 0 derivative securities held.
What were the exercise prices and terms of the disposed OWLT warrants?
One warrant had a $4.44 exercise price (exercisable 02/17/2023 to 02/17/2028); another had $4.09 (exercisable 02/29/2024 to 03/01/2029).
What is the reporting person’s relationship to Owlet (OWLT)?
The reporting person is a Director of Owlet, Inc.